Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16627670 | 0.76 | ALDH1A1 (0.37) | CA2ALDH1A1TDP1 | |
| SCHEMBL17177260 | 0.76 | ALDH1A1 (0.42) | CA2ALDH1A1TDP1 | |
| SCHEMBL19996626 | 0.75 | ALDH1A1 (0.36) | CA2USP2TSHRALDH1A1TDP1 | |
| SCHEMBL10534323 | 0.74 | NPSR1 (0.46) | TSHRALDH1A1TDP1 | |
| SCHEMBL10358202 | 0.74 | NPSR1 (0.46) | TSHRALDH1A1TDP1 | |
| SCHEMBL16373084 | 0.73 | CA1 (0.37) | CA2CA1BIRC2USP2TSHR | |
| SCHEMBL16373089 | 0.72 | CA2 (0.39) | CA2CA1USP2TSHRALDH1A1 | |
| SCHEMBL18288141 | 0.72 | CA2 (0.39) | CA2CA1USP2TSHRALDH1A1 | |
| SCHEMBL26345845 | 0.66 | CA2 (0.35) | CA2CA1USP2TSHRTDP1 | |
| SCHEMBL23636187 | 0.66 | CA1 (0.42) | CA2CA1USP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760770-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-20160359122-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760770-B2 | Organic electroluminescent materials and devices | LEF1, L1CAM, AP1M1 | CA2 1130/4885CA1 676/4885BIRC2 1619/4885 |
| US-20160359122-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZFR, EML4, SOD1 | CA2 3165/4885CA1 4166/4885BIRC2 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.